Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
City Therapeutics
Biotech
City scores $200M IPO as Frazier takes biotech SPAC to Nasdaq
City has gone public with an upsized $200 million IPO on the same day that Frazier Life Sciences listed its second biotech-focused shell company.
James Waldron
Oct 16, 2026 2:47am
TRex rakes in $117M IPO, while Retension reveals $45M listing
Oct 9, 2026 4:29am
ADARx scores upsized $446M IPO, while City maps out Nasdaq plans
Sep 25, 2026 2:46am
Former Legend CEO lands at K2—Chutes & Ladders
Aug 14, 2026 8:30am
City lays foundation for RNAi renaissance with nearly $100M
Jun 8, 2026 4:00pm
AN Venture Partners raises $200M to boost Japan biotech industry
Jul 2, 2025 11:45am
